Medicare Officially Limits Coverage of Aduhelm to Patients in Clinical Trials
Ever since Medicare proposed to sharply limit coverage of the controversial Alzheimer’s drug Aduhelm, the agency has been deluged with impassioned pleas.Groups representing patients insisted the federal insurance program pay for the…